ASCO 2021: Nivolumab plus ipilimumab for the treatment of kidney cancer brain metastases
Brain metastases resulting from the spread of renal cell carcinoma [...]
Brain metastases resulting from the spread of renal cell carcinoma [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
The cabozantinib/nivolumab combination has been shown to be effective at [...]
Cell metabolism in renal cell carcinoma (RCC) tumours is disrupted, [...]
Results from the phase 3 CLEAR study were presented at [...]
The cabozantinib/nivolumab combination has been shown to be effective at [...]
Adjuvant therapy is medication that is given in addition to [...]
Combinations of immunotherapy drugs nivolumab plus ipilimumab and immunotherapy/vascular endothelial [...]
Results from the phase 3 CLEAR study, presented at the [...]
A gene called MET codes for a protein called MET [...]